-->
United States chocolate powder market was valued at US$ 3,993.32 million in 2022 and a projected to generate a revenue of US$ 5,733.11 million by 2031 at a CAGR of 4.1% during the forecast period.
Latin America insulin market was valued at US$ 2,855.1 million in 2022 and is projected to attain a valuation of US$ 3,857.50 million by 2031 at a CAGR of 3.4% during the forecast period 2023–2031.
Southeast Asia intelligent toilet seat cover market was valued at US$ 564 million in 2022 and is projected to reach a valuation of US$ 852 million in 2031 at a CAGR of 4.7% during the forecast period 2023–2031.
Japan enterprise file synchronization and sharing (EFSS) market was valued at US$ 217.1 million in 2022 and is projected to attain a valuation of US$ 1,347.2 million by 2031 at a CAGR of 23.54% during the forecast period 2023–2031.
The global BCG tuberculosis vaccine market was valued at US$63.58 million in 2022 and is expected to attain a market valuation of US$ 91.10 million by 2031, at a CAGR of 4.5% during the forecast period (2023-2031).
The global anthrax vaccine market is expected to grow at a steady CAGR of 6.7%, fueled by increasing bioterrorism threats and growing awareness about the disease. As of 2022, the market was valued at US$ 599 million and is expected to surpass valuation of US$ 1,006.33 million by 2031.
Global chronic pain management market was valued at US$ 93.31 billion in 2022 and is expected to attain market size of US$ 168.68 billion by 2031 at a CAGR of 6.8% during the forecast period 2023–2031.